Herschel Mehlman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Herschel Mehlman has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Asaph Aharoni
Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel
1 shared publication - David Meiri
Laboratory of Cancer Biology and Natural Drug Discovery, Faculty of Biology, Technion—Israel Institute of Technology, Haifa 3200003, Israel
1 shared publication Efrat Almekias-Siegl
Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel
1 shared publication- Ilana Rogachev
Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel
1 shared publication - Janka Höfer
Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel
1 shared publication Let Kho Hao
Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel
1 shared publication
Latest Publications
- Open Access
- 3 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (14) , eaeb3034
Complete biosynthesis of psychedelic tryptamines from three kingdoms in plants
Psychedelic indolethylamines with therapeutic potential are naturally produced in plants, fungi, and animals. Here, we elucidated the complete N , N -dimethyltryptamine (DMT) biosynthetic pathway in hallucinogenic plant species traditionally used in shamanic rituals for spiritual healing. Leveraging the similarities in their chemical structures, we reconstructed in one plant assay the full biosynthetic pathways of five renowned natural psychedelics; psilocin and psilocybin found in mushrooms, DMT from plants, and bufotenin and 5-methoxy-DMT secreted by the Sonoran Desert toad. We further engineered halogenated analogs of these molecules, which do not naturally occur in plants and exhibit prospective therapeutic potential for psychiatric conditions. Blending catalytic functions across the tree of life, coupled with metabolic engineering guided by rational protein design of mutant enzymes, enabled substantially more efficient in planta production of the indolethylamine components. This work establishes a versatile platform for concurrent biosynthesis and diversification of psychoactive indolethylamines, paving the way for their production in plants.
- 3 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (14) , eaeb3034
Open AccessComplete biosynthesis of psychedelic tryptamines from three kingdoms in plants
Psychedelic indolethylamines with therapeutic potential are naturally produced in plants, fungi, and animals. Here, we elucidated the complete N , N -dimethyltryptamine (DMT) biosynthetic pathway in hallucinogenic plant species traditionally used in shamanic rituals for spiritual healing. Leveraging the similarities in their chemical structures, we reconstructed in one plant assay the full biosynthetic pathways of five renowned natural psychedelics; psilocin and psilocybin found in mushrooms, DMT from plants, and bufotenin and 5-methoxy-DMT secreted by the Sonoran Desert toad. We further engineered halogenated analogs of these molecules, which do not naturally occur in plants and exhibit prospective therapeutic potential for psychiatric conditions. Blending catalytic functions across the tree of life, coupled with metabolic engineering guided by rational protein design of mutant enzymes, enabled substantially more efficient in planta production of the indolethylamine components. This work establishes a versatile platform for concurrent biosynthesis and diversification of psychoactive indolethylamines, paving the way for their production in plants.